The End Kidney Deaths Act establishes a \$50,000 federal tax credit over five years for individuals who make non-directed living kidney donations between 2027 and 2036.
Nicole Malliotakis
Representative
NY-11
The End Kidney Deaths Act establishes a new federal tax credit for individuals who make non-directed living kidney donations. Eligible donors will receive an annual \$10,000 tax credit for five consecutive years, totaling a potential \$50,000 benefit. This provision is designed to incentivize altruistic donation while ensuring the credit is not considered payment for the organ.
The “End Kidney Deaths Act” is pretty direct about its goal, and the first major section lays out a massive new incentive to help get there. This bill creates a brand new federal tax credit specifically for people who make a “qualified non-directed living kidney donation.” Essentially, if you donate a kidney while you’re alive to a stranger through the organ matching system, the government wants to give you a serious thank you.
Here’s the deal: If you donate a kidney after December 31, 2026, you become eligible for a $10,000 tax credit in the year of the donation and for the next four years after that. That’s a potential total of $50,000 in tax credits over five years. For a busy person juggling a mortgage and rising costs, that kind of tax relief is huge—it could easily cover lost wages, travel costs, and recovery expenses, and then some. The program runs for ten years, sunsetting for any donations made after December 31, 2036.
One critical detail involves the donor’s well-being. If the donor passes away during that five-year credit period, the bill ensures their family or estate still gets the full benefit. The remaining balance of the $50,000 is accelerated and paid out in the year of death. This is a smart provision that protects the donor's financial commitment to their family, even in the event of tragedy.
Crucially, the bill also addresses the ethical elephant in the room: the federal ban on selling human organs. It explicitly states that this tax credit is not considered “valuable consideration” under the National Organ Transplant Act. This is the bill’s way of saying, “This is an incentive to encourage altruism, not a paycheck for an organ.” This legal distinction is necessary to keep the incentive program compliant with existing federal law and ethical standards.
This provision is designed to directly address the severe shortage of transplantable organs by encouraging more people to become non-directed donors—the ultimate act of medical altruism. If successful, this could significantly reduce the thousands of people currently waiting for a kidney. For the regular taxpayer, however, it’s worth noting that every dollar given out as a tax credit is a dollar of federal revenue foregone, meaning the public is subsidizing this incentive program. Also, if you choose to donate a kidney to a specific family member or friend (a “directed donation”), or participate in a chain donation, you do not qualify for this specific $50,000 credit, which could feel like a missed opportunity for those making equally life-saving, but less anonymous, donations.